CA2000932A1 - Forme pharmaceutique orale multiparticulaire a liberation controlee - Google Patents

Forme pharmaceutique orale multiparticulaire a liberation controlee

Info

Publication number
CA2000932A1
CA2000932A1 CA2000932A CA2000932A CA2000932A1 CA 2000932 A1 CA2000932 A1 CA 2000932A1 CA 2000932 A CA2000932 A CA 2000932A CA 2000932 A CA2000932 A CA 2000932A CA 2000932 A1 CA2000932 A1 CA 2000932A1
Authority
CA
Canada
Prior art keywords
controlled release
oral pharmaceutical
dosage form
unit dosage
multiple unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2000932A
Other languages
English (en)
Other versions
CA2000932C (fr
Inventor
Karin Malmqvist-Granlund
Christer Hermansson
Soren Kulstad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gacell Laboratories AB
Original Assignee
Leo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo AB filed Critical Leo AB
Publication of CA2000932A1 publication Critical patent/CA2000932A1/fr
Application granted granted Critical
Publication of CA2000932C publication Critical patent/CA2000932C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002000932A 1988-10-26 1989-10-18 Forme pharmaceutique orale multiparticulaire a liberation controlee Expired - Fee Related CA2000932C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8803822-9 1988-10-26
SE19888803822A SE8803822D0 (sv) 1988-10-26 1988-10-26 Novel dosage form
SG123894A SG123894G (en) 1988-10-26 1994-08-25 Novel dosage form

Publications (2)

Publication Number Publication Date
CA2000932A1 true CA2000932A1 (fr) 1990-04-26
CA2000932C CA2000932C (fr) 1999-12-28

Family

ID=26660328

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002000932A Expired - Fee Related CA2000932C (fr) 1988-10-26 1989-10-18 Forme pharmaceutique orale multiparticulaire a liberation controlee

Country Status (9)

Country Link
EP (1) EP0365947B1 (fr)
JP (1) JPH082783B2 (fr)
AU (1) AU612525B2 (fr)
CA (1) CA2000932C (fr)
DE (1) DE68907177T2 (fr)
ES (1) ES2055775T3 (fr)
HK (1) HK123394A (fr)
SE (1) SE8803822D0 (fr)
SG (1) SG123894G (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202250D0 (sv) * 1992-07-29 1992-07-29 Gacell Lab Ab Controlled release morphine preparation
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
PT1078628E (pt) * 1994-07-08 2009-01-27 Astrazeneca Ab Forma de dosagem em comprimidos com unidades múltiplas
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
DE59905248D1 (de) * 1999-01-29 2003-05-28 Disphar Int Bv Pharmazeutische zusammensetzungen
SE0001151D0 (sv) * 2000-03-31 2000-03-31 Amarin Dev Ab Method for producing a controlled-release composition
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
IL161857A0 (en) * 2001-11-30 2005-11-20 Pfizer Prod Inc Pharmaceutical compositions of 5,7,14-triazatetracycloÄ10.3.1.0(2,11).0(4,9)Ü-hexadeca-2(11)3,5,7,9-pentaene
JP2005104914A (ja) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk 塩基性薬剤含有製剤
EP2010161A2 (fr) * 2006-04-17 2009-01-07 Actavis Group PTC HF Formes posologiques orales et méthodes de préparation de celles-ci

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
CA1239034A (fr) * 1984-08-17 1988-07-12 Kelly L. Smith Systeme de dispensation
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules

Also Published As

Publication number Publication date
ES2055775T3 (es) 1994-09-01
JPH02164821A (ja) 1990-06-25
EP0365947B1 (fr) 1993-06-16
EP0365947A1 (fr) 1990-05-02
SE8803822D0 (sv) 1988-10-26
AU612525B2 (en) 1991-07-11
JPH082783B2 (ja) 1996-01-17
AU4365089A (en) 1990-05-03
CA2000932C (fr) 1999-12-28
DE68907177D1 (de) 1993-07-22
HK123394A (en) 1994-11-18
SG123894G (en) 1995-03-17
DE68907177T2 (de) 1994-01-13

Similar Documents

Publication Publication Date Title
CA2000932A1 (fr) Forme pharmaceutique orale multiparticulaire a liberation controlee
ATE246505T1 (de) Zubereitung enthaltend cefaclor oder cephalexin mit modifizierter freisetzungsmatrix
ES8702138A1 (es) Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo.
CA2198630A1 (fr) Formulation d'acetomiphene a liberation prolongee
AU7534087A (en) Sustained release pharmaceutical compositions in oral dosage form
DE69616795D1 (de) Formulierungen mit gesteuerter freisetzung für schwerlösliche arzneistoffe
CA2186039A1 (fr) Nouvelle forme galenique pharmaceutique orale
BG100933A (en) Polymer coated tablets comprising amoxycilin and clavulanate
CA2170647A1 (fr) Forme posologique sous forme de comprime composite (i)
CA2181502A1 (fr) Preparation pharmaceutique sous forme de capsule enrobee, liberee dans la partie inferieure du tube digestif
CA2039456A1 (fr) Appareil de dosage osmotique pour l'administration de medicaments liquides
CA2209714A1 (fr) Formulation a liberation controlee pour medicaments basiques peu solubles
AU4121297A (en) Galenic form with extended release of milnacipran
ATE244002T1 (de) Pharmazeutische formulierung mit omeprazol
NO175186C (no) Fremgangsmåte for fremstilling av et osmotisk avgivende, oralt avleveringssystem inneholdende et moderat vannopplöselig, farmasöytisk akseptabelt salt av metoprolol
CA2383212A1 (fr) Dosage oral a liberation regulee destine a l'administration orale
CA2256751A1 (fr) Comprime enrobe a base de maleate de trimebutine
CA2356306A1 (fr) Phosphatidylinositols sulfates, leur preparation et utilisation
SE9903879D0 (sv) Multipor food protection
EP0761209A3 (fr) Formulations de la ranitidine à libération commandée

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed